Japan’s Medical Device Market Set to Reach $74.7 Billion in 2025


The Japanese medical device market is set to reach from $54.5 billion in 2018 to $74.7 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.6% says GlobalData, a leading data and analytics company.

Japan stands as the world’s second-biggest medical device market, after the US. GlobalData’s latest report CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan, discovers that a conducive environment for improved medical products and new technological innovation for better healthcare, make Japan more open and attractive place for healthcare investment.

Renuka Sreeramoju, Medical Device Analyst at GlobalData, said “The rapidly aging Japanese population, increasing number of patients with chronic and life-style diseases, universal health insurance coverage, and regulatory measures are driving the Japanese medical device market. Even though the increasing elderly population provides a unique business opportunity for many international medical device companies to innovate new products, foreign investment into the untapped Japanese market was due to lack of knowledge on domestic companies.”

Against this backdrop, the Japanese government has taken new initiatives to streamline the regulatory approval review process and accelerate the launch of innovative medical products. In addition, various steps taken by the Ministry of Health, Labor and Welfare (MHLW) to improve the transparency of the approval review system substantially to accomplish a quick review process, which is equivalent to, or faster than that of North American and European markets. The government also introduced Medical Information Database to provide access to medical records for the innovators, which has led to quicker medical device development and faster patient access.

The changes to the regulatory review system resulted in increasing the number of partnerships, licensing deals, and research collaborations among the medical device companies in Japan. For example, German-based KARL STORZ partnered with Medicaroid Corporation to develop robotic-assisted surgery systems and Fujirebio and US-based Janssen Pharmaceuticals collaborated to develop AMYLOID β 42/40 RATIO immunoassay for Alzheimer’s dementia. FUJIFILM Corporation collaborated with Indiana University School of Medicine to develop artificial intelligence (AI) application in medical imaging diagnostic support systems.

In addition to traditional healthcare companies, Cyberdyne (Hybrid Assistive Limb (HAL) robotic exoskeleton unit), Cyfuse (3-D tissue fabrication system) and CureApp (medical-care applications for smartphones) are some of the medical device start-ups established in Japan that are expected to improve the healthcare outcome and patient’s experience.

Sreeramoju concludes “Favorable regulatory landscape, aging demographics, better access to medical data, innovative research and development, and increasing international collaborations will not only attract medical device start-ups, but also encourage AI and other technological start-ups to invest in healthcare sector in Japan.”

To gain access to our latest press releases: GlobalData Media Centre

Analysts available for comment. Please contact the GlobalData Press Office:

EMEA & Americas: +44 (0)207 832 4399
Asia-Pacific: +91 40 6616 6809
Email: pr@globaldata.com

To gain access to our latest press releases and expert analysis on developments in your industry, please connect with us on: GlobalData | LinkedIn | Twitter

The report is an essential source of information and analysis on the healthcare, regulatory, and reimbursement landscape in Japan. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape, and healthcare infrastructure of Japan. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.

4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.

Share This